The Adenovirus Type 4 and Type 7 Vac, cataloged under National Stock Number 6505-01-642-0106, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-642-0106 |
| Primary Part Number | NDC51285-0138-50 |
| Item Name | Adenovirus Type 4 and Type 7 Vac |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC51285-0138-50 PRIMARY | Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc (USA) |
| NDC51285-0138-50 | Teva Pharmaceuticals Usa, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM151649 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1281637 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-642-0106 is a Adenovirus Type 4 and Type 7 Vac, manufactured by Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-642-0106 has 2 manufacturer part numbers on file: NDC51285-0138-50 (Barr Laboratories, Inc. Dba Barr Laboratories, Inc Inc), NDC51285-0138-50 (Teva Pharmaceuticals Usa, Inc.).
Key specifications for NDC51285-0138-50: Special Features: CONTAINS VIABLE, SELECTED STRAINS OF HUMAN ADENOVIRUS TYPE 4 AND HUMAN ADENOVIRUS TYPE 7 PREPARED IN HUMAN-DIPLOID FIBROBLAST CELL CULTURES (STRAIN WI-38); VIRUS STRAINS HAVE NOT BEEN ATTENUATED; CELLS ARE GROWN AND THE VIRUS GROWTH MAINTAINED IN DULBECCO'S MODIFIED EAGLE'S MEDIUM, FETAL BOVINE SERUM, AND SODIUM BICARBONATE; APPROVED FOR USE IN MILITARY POPULATIONS 17-50 YEARS OF AGE; INDICATED FOR ACTIVE IMMUNIZATION FOR THE PREVENTION OF FEBRILE ACUTE RESPIRATORY DISEASE CAUSED BY ADENOVIRUS TYPE 4 AND TYPE 7; CARTON CONSISTS OF ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 4 (NDC 51285-174-02) AND ONE BOTTLE OF 100 TABLETS ADENOVIRUS TYPE 7 (NDC 51285-175-02); STORE REFRIGERATED BETWEEN 2-8 DEG C (35-46 DEG F); DO NOT FREEZE; KEEP BOTTLE TIGHTLY CLOSED AND PROTECT FROM MOISTURE; DO NOT REMOVE DESICCANT CANISTER FROM BOTTLE; PRESCRIPTION ONLY; FOR ORAL ADMINISTRATION; DOSAGE: ONE TABLET OF ADENOVIRUS TYPE 4 COMPONENT AND ONE TABLET OF ADENOVIRUS TYPE 7 COMPONENT DEGC; Part Name Assigned by Controlling Agency: ADENOVIRUS TYPE 4 AND TYPE 7 VACCINE LIVE ORAL ENTERIC COATED TABLETS 200S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.